Cardiogen

Cardiogen is a short tetrapeptide bioregulator developed by the St. Petersburg Institute of Bioregulation and Gerontology (Russia). It targets cardiac muscle tissue to improve myocardial function, particularly in conditions of ischemia, aging-related cardiac decline, and heart failure.

• Improves myocardial function
• Reduces cardiac ischemia damage
• Anti-arrhythmic effects
• Supports cardiac energy metabolism
• May reduce cardiac aging markers

• Generally well tolerated
• Hypotension risk at higher doses
• Injection site reactions